Digital therapeutics face barriers to growth as Pear takes early steps toward sales targets

Support for rapid updates, the limitations of current reimbursement policies, cybersecurity risks as well as a “pressing need” for new regulatory frameworks are among the challenges facing DTx companies, according to researchers.